These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33487619)

  • 1. Prognostic Value of the CHA
    Tomoi Y; Takahara M; Soga Y; Fujihara M; Iida O; Kawasaki D; Kozuki A; Ando K
    J Atheroscler Thromb; 2021 Nov; 28(11):1153-1160. PubMed ID: 33487619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Guo T; Xi Z; Qiu H; Wang Y; Zheng J; Dou K; Xu B; Qiao S; Yang W; Gao R
    Ann Med; 2021 Dec; 53(1):2215-2224. PubMed ID: 34791980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Suitability of CHA
    Cheng YT; Chang FL; Li PH; Lu WC; Chiu CS
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of the CHADS
    Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the pre-admission CHA2DS2-VASc score and proximal artery occlusion in patients with acute stroke and atrial fibrillation.
    Sakamoto Y; Sato S; Hama Y; Nagatsuka K; Minematsu K; Toyoda K
    Eur J Neurol; 2015 Jul; 22(7):1081-7. PubMed ID: 25856091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
    Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA
    Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS
    Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHA
    Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive interaction between chronic obstructive pulmonary disease and CHA
    Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
    Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the CHA
    Chua SK; Huang PS; Chen JJ; Chiu FC; Hwang JJ; Tsai CT
    Hellenic J Cardiol; 2024; 78():42-49. PubMed ID: 37633490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using CHADS
    Chi NY; Su HM; Lee WH; Tsai WC; Chen YC; Lin TC; Lu YH; Lee CS; Lin TH; Lai WT; Sheu SH; Hsu PC
    Int J Med Sci; 2021; 18(1):276-283. PubMed ID: 33390796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    Kabra R; Girotra S; Vaughan Sarrazin M
    J Am Coll Cardiol; 2016 Aug; 68(5):461-470. PubMed ID: 27470453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.
    Yoon M; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Thromb Haemost; 2018 Jul; 118(7):1296-1304. PubMed ID: 29723875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHADS
    Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P
    J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
    Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Marín F; Lip GYH
    Thromb Haemost; 2021 Aug; 121(8):1107-1114. PubMed ID: 33296920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of CHA
    Sonaglioni A; Caminati A; Re M; Elia D; Trevisan R; Granato A; Zompatori M; Lombardo M; Harari S
    Intern Emerg Med; 2023 Apr; 18(3):755-767. PubMed ID: 36966265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.